NF- B as a therapeutic target in cancer

By Orlowski R.Z.   Baldwin A.S.  

Trends in Molecular Medicine, Vol. 8, Iss. 8, 2002-08 ,pp. : 385-389

Elsevier

Access to resources Recommend Favorite

Targeting ErbB3: the New RTK(id) on the Prostate Cancer Block

By  

Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Immunology, Endocrine and Metabolic Agents), Vol. 11, Iss. 2, 2011-06 ,pp. : 131-149

Bentham Science Publishers

Access to resources Recommend Favorite

HspB1 Dynamic Phospho-Oligomeric Structure Dependent Interactome as Cancer Therapeutic Target

By  

Current Molecular Medicine, Vol. 12, Iss. 9, 2012-11 ,pp. : 1151-1163

Bentham Science Publishers

Access to resources Recommend Favorite

Structure-based approaches to inhibition of erbB receptors with peptide mimetics

By Berezov Alan   Greene Mark   Murali Ramachandran  

Immunologic Research, Vol. 27, Iss. 2-3, 2003-06 ,pp. : 303-308

Humana Press, Inc

Access to resources Recommend Favorite

NF- B as a therapeutic target in chronic inflammation: recent advances

By Makarov S.S.  

Molecular Medicine Today, Vol. 6, Iss. 11, 2000-11 ,pp. : 441-448

Elsevier

Access to resources Recommend Favorite